Michael Petroutsas ’97, vice president of the US Oncology Business Unit of GSK, one of the world’s largest pharmaceutical manufacturers, joined the Washington Post’s “Chasing Cancer” speaker series to discuss the impacts of COVID-19 on cancer care. Petroutsas is delivering transformational medicines and programs that provide enduring impact and hope for cancer patients.
